{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T10:15:25Z","timestamp":1773656125638,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.heliyon.2020.e03767","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T15:59:24Z","timestamp":1586534364000},"page":"e03767","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prognostic factors for remission, relapse, and treatment complications in type 1 autoimmune hepatitis"],"prefix":"10.1016","volume":"6","author":[{"given":"Nitipat","family":"Sandusadee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5065-9397","authenticated-orcid":false,"given":"Wattana","family":"Sukeepaisarnjaroen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8237-8645","authenticated-orcid":false,"given":"Tanita","family":"Suttichaimongkol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2020.e03767_bib1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","article-title":"Autoimmune hepatitis","volume":"354","author":"Krawitt","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.heliyon.2020.e03767_bib2","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2020.e03767_bib3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365529850166284","article-title":"Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population","volume":"33","author":"Boberg","year":"1998","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.heliyon.2020.e03767_bib4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(87)92024-1","article-title":"Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen","volume":"1","author":"Manns","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2020.e03767_bib5","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/hep.22432","article-title":"Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: implications for follow-up and screening","volume":"48","author":"Yeoman","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2020.e03767_bib6","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ncpgasthep0768","article-title":"Current therapy for autoimmune hepatitis","volume":"4","author":"Montano Loza","year":"2007","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"10.1016\/j.heliyon.2020.e03767_bib7","doi-asserted-by":"crossref","first-page":"6030","DOI":"10.3748\/wjg.v23.i33.6030","article-title":"Autoimmune hepatitis: standard treatment and systematic review of alternative treatments","volume":"23","author":"Terziroli Beretta-Piccoli","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.heliyon.2020.e03767_bib8","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/gut.16.11.876","article-title":"Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared","volume":"16","author":"Summerskill","year":"1975","journal-title":"Gut"},{"key":"10.1016\/j.heliyon.2020.e03767_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/2040622313478646","article-title":"Treatment of autoimmune liver disease: current and future therapeutic options","volume":"4","author":"Trivedi","year":"2013","journal-title":"Ther. Adv. Chronic Dis."},{"key":"10.1016\/j.heliyon.2020.e03767_bib10","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0016-5085(88)90503-3","article-title":"Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis","volume":"95","author":"Czaja","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.heliyon.2020.e03767_bib11","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/hep.21787","article-title":"Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease","volume":"46","author":"Montano-Loza","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2020.e03767_bib12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1440-1746.2010.06579.x","article-title":"Treatment of autoimmune hepatitis: a review of current and evolving therapies","volume":"26","author":"Jothimani","year":"2011","journal-title":"J.\u00a0Gastroenterol. Hepatol."},{"key":"10.1016\/j.heliyon.2020.e03767_bib13","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.dld.2016.06.018","article-title":"Predictive factors of poor\u00a0response to therapy in Autoimmune Hepatitis","volume":"48","author":"Muratori","year":"2016","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.heliyon.2020.e03767_bib14","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1002\/hep.26290","article-title":"Predictors of poor outcome in patients w ith autoimmune hepatitis: a population-based study","volume":"57","author":"Ngu","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2020.e03767_bib15","first-page":"749","article-title":"Predictive factors for remission and death in 73 patients with autoimmune hepatitis in Japan","volume":"11","author":"Hino","year":"2003","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.heliyon.2020.e03767_bib16","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/jgh.12952","article-title":"Autoimmune hepatitis: east meets west","volume":"30","author":"Yang","year":"2015","journal-title":"J.\u00a0Gastroenterol. Hepatol."},{"key":"10.1016\/j.heliyon.2020.e03767_bib17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.2008.03722.x","article-title":"Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival","volume":"28","author":"Al-Chalabi","year":"2008","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.heliyon.2020.e03767_bib18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2020.e03767_bib19","first-page":"326","article-title":"The overlap syndromes of autoimmune hepatitis","volume":"58","author":"Czaja","year":"2013","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.heliyon.2020.e03767_bib20","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.heliyon.2020.e03767_bib21","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3325\/cmj.2014.55.514","article-title":"New classification criteria for systemic lupus erythematosus correlate with disease activity","volume":"55","author":"Ani\u0107","year":"2014","journal-title":"Croat. Med. J."},{"key":"10.1016\/j.heliyon.2020.e03767_bib22","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1053\/jhep.2002.32485","article-title":"Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis","volume":"35","author":"Czaja","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2020.e03767_bib23","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1007\/s10620-017-4728-2","article-title":"Treatment response and outcome with two different prednisolone regimens in autoimmune hepatitis","volume":"62","author":"Purnak","year":"2017","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.heliyon.2020.e03767_bib24","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/0016-5085(80)90866-5","article-title":"Clinical features and prognosis of severe chronic active liver disease (CALD) after corticosteroid-induced remission","volume":"78","author":"Czaja","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1016\/j.heliyon.2020.e03767_bib25","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1136\/gut.2010.235259","article-title":"British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis","volume":"60","author":"Gleeson","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.heliyon.2020.e03767_bib26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jhep.2012.09.009","article-title":"Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission","volume":"58","author":"van Gerven","year":"2013","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.heliyon.2020.e03767_bib27","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jhep.2014.05.021","article-title":"Prognosis of acute severe autoimmune hepatitis (AS-AIH): the role of corticosteroids in modifying outcome","volume":"61","author":"Yeoman","year":"2014","journal-title":"J.\u00a0Hepatol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844020306125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844020306125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T09:41:37Z","timestamp":1773654097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844020306125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S2405844020306125"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2020.e03767","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic factors for remission, relapse, and treatment complications in type 1 autoimmune hepatitis","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2020.e03767","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e03767"}}